{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:18Z","timestamp":1786993698752,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,8]],"date-time":"2018-04-08T00:00:00Z","timestamp":1523145600000},"content-version":"vor","delay-in-days":97,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.lrr.2018.04.005","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T02:06:44Z","timestamp":1523844404000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature"],"prefix":"10.1016","volume":"9","author":[{"given":"Daria","family":"Gaut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9866-462X","authenticated-orcid":false,"given":"Joshua","family":"Sasine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lrr.2018.04.005_bib0001","first-page":"1014","volume":"90","author":"Mandelli","year":"1997","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.lrr.2018.04.005_bib0002","first-page":"3015","article-title":"A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML\/RARalpha-positive acute promyelocytic leukemia. PETHEMA group","volume":"94","author":"Sanz","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lrr.2018.04.005_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo Coco","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/shem.2001.20861","article-title":"Acute promyelocytic leukemia: Clinical and morphologic features and prognostic factors","volume":"38","author":"Avvisati","year":"2001","journal-title":"Semin. Hematol."},{"issue":"4","key":"10.1016\/j.lrr.2018.04.005_bib0005","first-page":"1247","article-title":"Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups","volume":"96","author":"Sanz","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lrr.2018.04.005_bib0006","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0165-4608(02)00859-2","article-title":"Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: clinical and genetic features of two cases","volume":"143","author":"Panizo","year":"2003","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0007","first-page":"102","article-title":"A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia","volume":"86","author":"Pecci","year":"2001","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.lrr.2018.04.005_bib0008","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.1993.tb04709.x","article-title":"A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukaemia (M1) with t(7;21) at relapse","volume":"83","author":"Jubashi","year":"1993","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.lrr.2018.04.005_bib0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0165-4608(94)90002-7","article-title":"Translocation (3;21)(q26;q22) in treatment-related acute leukemia secondary to acute promyelocytic leukemia","volume":"74","author":"Miyazaki","year":"1994","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.leu.2400539","article-title":"Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia","volume":"11","author":"Bseiso","year":"1997","journal-title":"Leukemia"},{"issue":"3-4","key":"10.1016\/j.lrr.2018.04.005_bib0011","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/10428199909050968","article-title":"Acute trilineage leukemia with monosomy of chromosome 7 following an acute promyelocytic leukemia","volume":"34","author":"Felice","year":"1999","journal-title":"Leuk. Lymphoma."},{"issue":"9","key":"10.1016\/j.lrr.2018.04.005_bib0012","first-page":"1583","article-title":"Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia","volume":"9","author":"Todisco","year":"1995","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.lrr.2018.04.005_bib0013","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood.V90.3.1321","article-title":"Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML\/RAR alpha fusion gene","volume":"90","author":"Meloni","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0014","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajh.2830480108","article-title":"Acute promyelocytic leukaemia (M3): relapse with acute myeloblastic leukaemia (M2) and dic(5;17) (q11;p11)","volume":"48","author":"Hatzis","year":"1995","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.lrr.2018.04.005_bib0015","first-page":"270","article-title":"Therapy-related acute myeloid leukemia with t(10;11)(q23;p15) following successful chemotherapy for acute promyelocytic leukemia with t(15;17)(q22;q21)","volume":"69","author":"Sawada","year":"1999","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.lrr.2018.04.005_bib0016","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-2141.2000.02240.x","article-title":"Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature","volume":"110","author":"Zompi","year":"2000","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0017","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/hupa.2001.21128","article-title":"Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features","volume":"32","author":"Au","year":"2001","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.lrr.2018.04.005_bib0018","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood.V99.3.822","article-title":"Therapy-related myelodysplastic syndrome\u2013acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem","volume":"99","author":"Latagliata","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lrr.2018.04.005_bib0019","first-page":"85","article-title":"Therapy-related myelodysplastic syndrome following acute promyelocytic leukemia and biphenotypic acute leukemia following stem cell transplantation in the same patient","volume":"24","author":"G\u00fcnd\u00fcz","year":"2007","journal-title":"Turk. J. Haematol."},{"issue":"8","key":"10.1016\/j.lrr.2018.04.005_bib0020","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/sj.leu.2403034","article-title":"Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience","volume":"17","author":"Lobe","year":"2003","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.lrr.2018.04.005_bib0021","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/1042819021000040143","article-title":"Therapy-related myelodysplastic syndrome with monosomy 5 and 7 following successful therapy for acute promyelocytic leukemia with anthracyclines","volume":"43","author":"Athanasiadou","year":"2002","journal-title":"Leuk. Lymphoma."},{"issue":"4","key":"10.1016\/j.lrr.2018.04.005_bib0022","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.thj.6200256","article-title":"Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemia","volume":"4","author":"Annunziata","year":"2003","journal-title":"Hematol. J."},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0023","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-4608(99)00132-6","article-title":"Acute promyelocytic leukemia relapsing into FAB-M2 acute myeloid leukemia with trisomy 8","volume":"117","author":"Stavroyianni","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.lrr.2018.04.005_bib0024","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cancergencyto.2004.09.019","article-title":"Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia","volume":"159","author":"Lee","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1\u20132","key":"10.1016\/j.lrr.2018.04.005_bib0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10428199509059675","article-title":"t(15;17) hypergranular acute promyelocytic leukemia (M3) developing into a t(3;6) M3 without t(15;17) at relapse","volume":"19","author":"Desangles","year":"1995","journal-title":"Leuk. Lymphoma."},{"issue":"2","key":"10.1016\/j.lrr.2018.04.005_bib0026","first-page":"146","article-title":"Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature","volume":"28","author":"Betancourt-Garc\u00eda","year":"2009","journal-title":"P R Health Sci. J."},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0027","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0165-4608(97)00223-9","article-title":"Occurrence of a novel t(11;19)(q13;q13.3) in complete remission of acute promyelocytic leukemia","volume":"101","author":"Temperani","year":"1998","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.2002.03553.x","article-title":"Appearance of del(11q) in two patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and combination chemotherapy","volume":"118","author":"Campbell","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.lrr.2018.04.005_bib0029","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ajh.21528","article-title":"Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia","volume":"84","author":"Batzios","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.lrr.2018.04.005_bib0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/0971-5851.125261","article-title":"Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics","volume":"34","author":"Sahoo","year":"2013","journal-title":"Indian J. Med. Paediatr. Oncol."},{"issue":"2","key":"10.1016\/j.lrr.2018.04.005_bib0031","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cancergencyto.2007.10.003","article-title":"Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia","volume":"180","author":"Snijder","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.lrr.2018.04.005_bib0032","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cancergencyto.2005.11.013","article-title":"Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia","volume":"167","author":"Pawarode","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"issue":"9","key":"10.1016\/j.lrr.2018.04.005_bib0033","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.leu.2402616","article-title":"Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)","volume":"16","author":"Garcia-Manero","year":"2002","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.lrr.2018.04.005_bib0034","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.leukres.2006.10.003","article-title":"Could ATRA\/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission","volume":"31","author":"Mallo","year":"2007","journal-title":"Leuk. Res."},{"issue":"3","key":"10.1016\/j.lrr.2018.04.005_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10245330410001701503","article-title":"Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment","volume":"9","author":"Rund","year":"2004","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.lrr.2018.04.005_bib0036","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.seminoncol.2008.04.012","article-title":"Therapy-related myeloid leukemia","volume":"35","author":"Godley","year":"2008","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0037","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.lrr.2018.04.005_bib0038","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.leu.2403947","article-title":"Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients","volume":"19","author":"Rund","year":"2005","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.lrr.2018.04.005_bib0039","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gcc.1115","article-title":"Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents","volume":"31","author":"Andersen","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.lrr.2018.04.005_bib0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1098-2264(199812)23:4<337::AID-GCC9>3.0.CO;2-L","article-title":"Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases","volume":"23","author":"Pedersen-Bjergaard","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"issue":"7540","key":"10.1016\/j.lrr.2018.04.005_bib0041","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2014","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.lrr.2018.04.005_bib0042","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2017-03-775569","article-title":"SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia","volume":"130","author":"Mar","year":"2017","journal-title":"Blood"},{"issue":"7382","key":"10.1016\/j.lrr.2018.04.005_bib0043","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"issue":"149","key":"10.1016\/j.lrr.2018.04.005_bib0044","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004315","article-title":"Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia","volume":"4","author":"Jan","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.lrr.2018.04.005_bib0045","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/leu.2014.113","article-title":"Genomic analysis of the clonal origin and evolution of acute promyelocytic leukemia in a unique patient with a very late (17 years) relapse","volume":"28","author":"Zhang","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.lrr.2018.04.005_bib0046","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1309\/AJCPJ7K0AWMBHMAI","article-title":"Acute promyelocytic leukemia at time of relapse commonly demonstrates cytogenetic evidence of clonal evolution and variability in blast immunophenotypic features","volume":"133","author":"Dimov","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.lrr.2018.04.005_bib0047","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2400642","article-title":"Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases","volume":"11","author":"Fayad","year":"1997","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.lrr.2018.04.005_bib0048","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.leu.2402634","article-title":"Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8","volume":"16","author":"Andersen","year":"2002","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.lrr.2018.04.005_bib0049","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/annonc\/mdw171","article-title":"Current management of newly diagnosed acute promyelocytic leukemia","volume":"27","author":"Cicconi","year":"2016","journal-title":"Ann. Oncol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048918300098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048918300098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:07:40Z","timestamp":1761959260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048918300098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":49,"alternative-id":["S2213048918300098"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2018.04.005","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2018.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}